FMR »

Seres Therapeutics shares owned by FMR

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by FMR from 13F filings

Historical chart of FMR investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by FMR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by FMR

Quarter filed Position value Share count Share price at filing
2025-09-30 $36k 1.9k 19.24
2025-06-30 $3.0M 269k 11.11

More positions owned by FMR

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Netflix (NFLX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Ge Aerospace Com New (GE)
Wells Fargo & Company (WFC)

View all positions for FMR

Top funds holding Seres Therapeutics

Flagship Ventures Management
Susquehanna International
Vanguard Group
Marshall Wace
Hudson Bay Capital Management
BlackRock
Vontobel Holding
J. Goldman & Co
Citadel Advisors
Geode Capital Management
Caption Management
Jane Street
Charles Schwab Investment Management
State Street Corporation
Schonfeld Strategic Advisors

View all funds holding Seres Therapeutics